Pill halves risk of death in type of lung cancer

Credit: Pixabay/CC0 Public DomainA pill has been shown to halve the risk of death from a certain type of lung cancer when taken daily after surgery to remove the tumor, according to clinical trial res

Updated on: February 03,2024

Pill halves risk of death in type of lung cancer

Credit: Pixabay/CC0 Public DomainA pill has been shown to halve the risk of death from a certain type of lung cancer when taken daily after surgery to remove the tumor, according to clinical trial res

Updated on:February 03,2024

Specific components of the tumor immune microenvironment may affect responses to BCMA CAR T-cell therapy

byAmerican Association for Cancer ResearchCredit: Unsplash/CC0 Public DomainPatients with myeloma whose tumor immune microenvironments had a more diverse baseline T-cell repertoire, fewer marker

Updated on: January 22,2024

Specific components of the tumor immune microenvironment may affect responses to BCMA CAR T-cell therapy

byAmerican Association for Cancer ResearchCredit: Unsplash/CC0 Public DomainPatients with myeloma whose tumor immune microenvironments had a more diverse baseline T-cell repertoire, fewer marker

Updated on:January 22,2024

How metastatic cancer causes leaky blood vessels

byAmerican Institute of PhysicsImmunofluorescence images showing the effects of contactless paracrine signaling interactions (left) or physical contact (right) in micropatterned endothelial cell

Updated on: January 22,2024

How metastatic cancer causes leaky blood vessels

byAmerican Institute of PhysicsImmunofluorescence images showing the effects of contactless paracrine signaling interactions (left) or physical contact (right) in micropatterned endothelial cell

Updated on:January 22,2024

AI tool 'DeepHRD' accelerates cancer treatment decisions

byUniversity of California - San DiegoFirst author Erik Bergstrom showcasing a biopsy analysis completed with DeepHRD, a new artificial intelligence tool that can detect clinically actionable ge

Updated on: August 28,2024

AI tool 'DeepHRD' accelerates cancer treatment decisions

byUniversity of California - San DiegoFirst author Erik Bergstrom showcasing a biopsy analysis completed with DeepHRD, a new artificial intelligence tool that can detect clinically actionable ge

Updated on:August 28,2024

Pathology and social interactions—safety in numbers

by CNRSTumor cells, expressing green fluorescent protein, in digestive tract of the fruit fly Drosophila melanogaster. A dense tumor (left) is visible in the anterior midgut. Credit: © Andreu Cas

Updated on: March 01,2024

Pathology and social interactions—safety in numbers

by CNRSTumor cells, expressing green fluorescent protein, in digestive tract of the fruit fly Drosophila melanogaster. A dense tumor (left) is visible in the anterior midgut. Credit: © Andreu Cas

Updated on:March 01,2024

New precision therapy for bile duct cancer extends patients' lives

byUniversity College LondonCredit: Pixabay/CC0 Public DomainA new personalized cancer treatment can radically improve the outlook for some patients with bile duct cancer, finds an international

Updated on: January 12,2024

New precision therapy for bile duct cancer extends patients' lives

byUniversity College LondonCredit: Pixabay/CC0 Public DomainA new personalized cancer treatment can radically improve the outlook for some patients with bile duct cancer, finds an international

Updated on:January 12,2024

'Positive' trial for Pfizer-BioNTech COVID-flu jab

Credit: Unsplash/CC0 Public DomainGermany's BioNTech and US pharmaceutical giant Pfizer on Thursday announced "positive" results from initial trials of their combined mRNA vaccine agains

Updated on: March 01,2024

'Positive' trial for Pfizer-BioNTech COVID-flu jab

Credit: Unsplash/CC0 Public DomainGermany's BioNTech and US pharmaceutical giant Pfizer on Thursday announced "positive" results from initial trials of their combined mRNA vaccine agains

Updated on:March 01,2024

Old chemo drug, new pancreatic cancer therapy?

Updated on: September 10,2024

Old chemo drug, new pancreatic cancer therapy?

Updated on:September 10,2024

Everolimus inhibits angiogenesis and lymphangiogenesis in TP53 mutant HNSCC via STAT3/HIF-1α/VEGF pathway

by Impact Journals LLCEverolimus reduces microvessel density (MVD) and lymphatic vessel density (LVD) in TP53 mutant HNSCC xenografts. Credit:Oncotarget(2023). DOI: 10.18632/oncotarget.283

Updated on: February 03,2024

Everolimus inhibits angiogenesis and lymphangiogenesis in TP53 mutant HNSCC via STAT3/HIF-1α/VEGF pathway

by Impact Journals LLCEverolimus reduces microvessel density (MVD) and lymphatic vessel density (LVD) in TP53 mutant HNSCC xenografts. Credit:Oncotarget(2023). DOI: 10.18632/oncotarget.283

Updated on:February 03,2024

Combination therapy outperforms chemotherapy in clinical trial for patients with chronic lymphocytic leukemia

by University of AmsterdamCredit: Unsplash/CC0 Public DomainChemotherapy has been the most effective treatment to date for young and fit patients with chronic lymphocytic leukemia (CLL). The dise

Updated on: February 03,2024

Combination therapy outperforms chemotherapy in clinical trial for patients with chronic lymphocytic leukemia

by University of AmsterdamCredit: Unsplash/CC0 Public DomainChemotherapy has been the most effective treatment to date for young and fit patients with chronic lymphocytic leukemia (CLL). The dise

Updated on:February 03,2024

Researchers identify protein that may protect the heart during certain cancer treatment regimens

by Jacqueline Mitchell,Beth Israel Deaconess Medical CenterCirculating Hpx is elevated in mice treated with Dox. (A) Dox-induced chronic cardiomyopathy model in mice. i.p., intraperitoneally. (B

Updated on: February 18,2024

Researchers identify protein that may protect the heart during certain cancer treatment regimens

by Jacqueline Mitchell,Beth Israel Deaconess Medical CenterCirculating Hpx is elevated in mice treated with Dox. (A) Dox-induced chronic cardiomyopathy model in mice. i.p., intraperitoneally. (B

Updated on:February 18,2024

Research finds that life-saving intervention is not risk-free in pediatric patients

by Rachel Sauer,CU Anschutz Medical CampusCredit: Unsplash/CC0 Public DomainBlood transfusion is a vital and lifesaving intervention in a broad range of scenarios, from trauma response to cancer

Updated on: January 23,2024

Research finds that life-saving intervention is not risk-free in pediatric patients

by Rachel Sauer,CU Anschutz Medical CampusCredit: Unsplash/CC0 Public DomainBlood transfusion is a vital and lifesaving intervention in a broad range of scenarios, from trauma response to cancer

Updated on:January 23,2024